Fagron NV (OTCMKTS:ARSUF) Short Interest Update

Fagron NV (OTCMKTS:ARSUF) was the recipient of a large decline in short interest in December. As of December 31st, there was short interest totaling 3,076 shares, a decline of 51.4% from the December 15th total of 6,334 shares. Based on an average daily volume of 978 shares, the short-interest ratio is presently 3.1 days. Based on an average daily volume of 978 shares, the short-interest ratio is presently 3.1 days.

Fagron Stock Performance

ARSUF opened at $23.50 on Wednesday. The stock has a fifty day moving average of $23.50 and a 200-day moving average of $24.18. Fagron has a 12-month low of $23.50 and a 12-month high of $23.66.

Fagron Company Profile

Fagron (OTCMKTS:ARSUF) is a global pharmaceutical compounding company that supplies raw materials, equipment and services to compounding pharmacies, hospitals and healthcare practitioners. Its portfolio encompasses a range of pharmaceutical ingredients, dosage forms and specialized compounding solutions designed to meet patient-specific needs. The company supports the preparation of customized medications in areas such as dermatology, pain management, hormone replacement therapy and veterinary medicine, providing both sterile and non-sterile compounding products.

Headquartered in Rotterdam, the Netherlands, Fagron operates in more than 55 countries across Europe, the Americas, Asia-Pacific and the Middle East & Africa.